Continuing our interview series ahead of the Hevolution Global Healthspan Summit, we talk to Jorge Conde, a general partner at venture capital giant Andreessen Horowitz (a16z) Bio + Health to discover what’s making investors tick when it comes to healthspan. https://longevity.technology/news/investing-in-the-global-race-to-develop-healthspan-therapeutics/